FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 235 filers reported holding FATE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $424,000 | -55.6% | 200,000 | 0.0% | 0.14% | -46.3% |
| Q2 2023 | $956,000 | -16.1% | 200,000 | 0.0% | 0.27% | -13.8% |
| Q1 2023 | $1,140,000 | +98.2% | 200,000 | +250.9% | 0.31% | +110.1% |
| Q4 2022 | $575,130 | -55.0% | 57,000 | 0.0% | 0.15% | -57.8% |
| Q3 2022 | $1,277,000 | -9.6% | 57,000 | 0.0% | 0.35% | +5.7% |
| Q2 2022 | $1,412,000 | -36.1% | 57,000 | 0.0% | 0.33% | -26.5% |
| Q1 2022 | $2,209,000 | -33.8% | 57,000 | 0.0% | 0.45% | -32.2% |
| Q4 2021 | $3,335,000 | -1.3% | 57,000 | 0.0% | 0.67% | -7.1% |
| Q3 2021 | $3,378,000 | -37.2% | 57,000 | -8.1% | 0.72% | -30.1% |
| Q2 2021 | $5,380,000 | +0.4% | 62,000 | -4.6% | 1.03% | +2.3% |
| Q1 2021 | $5,359,000 | -21.4% | 65,000 | -13.3% | 1.00% | -23.6% |
| Q4 2020 | $6,819,000 | +70.6% | 75,000 | -25.0% | 1.31% | +58.7% |
| Q3 2020 | $3,997,000 | +16.5% | 100,000 | 0.0% | 0.83% | +11.0% |
| Q2 2020 | $3,431,000 | +209.1% | 100,000 | +100.0% | 0.75% | +191.4% |
| Q1 2020 | $1,110,000 | +13.5% | 50,000 | 0.0% | 0.26% | +34.0% |
| Q4 2019 | $978,000 | – | 50,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
| Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
| Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
| Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
| GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
| Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
| Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
| Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
| XTX Topco Ltd | 192,920 | $408,990 | 0.07% |